Gossamer Bio (GOSS) Price to Book (2019 - 2026)
Gossamer Bio (GOSS) posted Price to Book of 0.54 for Q2 2026, down 13.54% on a QoQ basis from 0.48 in Q1 2026, and up 91.02% year-over-year from 0.29 in Q2 2025.
Analysis
Gossamer Bio (GOSS) Price to Book (2019 - 2026) Analysis & Trends
Gossamer Bio has reported Price to Book for 8 years, with the latest figure at 0.54 in Q2 2026.
- On a quarterly basis, Price to Book rose 91.02% year-over-year to 0.54 in Q2 2026; TTM through Jun 2026 was 0.54, a 91.02% increase from a year earlier, with the FY2025 full-year figure at 5.9, down 185.33% from the prior year.
- Price to Book was 0.54 for Q2 2026 at Gossamer Bio, down from 0.48 in the prior quarter.
- The five-year high for Price to Book was 22.03 in Q1 2022, with the low at 39.99 in Q1 2025.
- Average Price to Book over 5 years is 1.05, with a median of 0.65 recorded in 2023.
- The largest YoY upside for Price to Book was 769.99% in 2022 against a maximum downside of 1517.09% in 2022.
- Over 5 years, Price to Book stood at 16.97 in 2022, then slumped by 86.96% to 2.21 in 2023, then soared by 212.53% to 6.92 in 2024, then plunged by 185.33% to 5.9 in 2025, then soared by 90.77% to 0.54 in 2026.
- The last three Price to Book figures came in at 0.54 (Q2 2026), 0.48 (Q1 2026), and 5.9 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
| 10 | Gossamer Bio | 57.60 Mn | 576,568.19 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.54 |
| Mar 31, 2026 | -0.48 |
| Dec 31, 2025 | -5.90 |
| Sep 30, 2025 | -7.39 |
| Jun 30, 2025 | -6.06 |
| Mar 31, 2025 | -39.99 |
| Dec 31, 2024 | 6.92 |
| Sep 30, 2024 | 4.14 |
| Jun 30, 2024 | 2.50 |
| Mar 31, 2024 | 9.99 |
| Dec 31, 2023 | 2.21 |
| Sep 30, 2023 | 1.79 |
| Jun 30, 2023 | -1.82 |
| Mar 31, 2023 | -4.23 |
| Dec 31, 2022 | 16.97 |
| Sep 30, 2022 | 19.97 |
| Jun 30, 2022 | -39.02 |
| Mar 31, 2022 | 22.03 |
| Dec 31, 2021 | 7.05 |
| Sep 30, 2021 | 5.57 |